Alopecia Treatment
SKU
MRR-A339DAEFA47E
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 3.26 billion
2030
USD 5.69 billion
2024
USD 3.53 billion
CAGR
8.27%
Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Global Forecast 2024-2030

[194 Pages Report] The Alopecia Treatment Market size was estimated at USD 3.26 billion in 2023 and expected to reach USD 3.53 billion in 2024, at a CAGR 8.27% to reach USD 5.69 billion by 2030.

Alopecia Treatment Market
To learn more about this report, request a free sample copy
Alopecia treatment encompasses a range of medical and cosmetic strategies used to address hair loss, which can be due to genetic factors, autoimmune disorders, medications, or other health conditions. Treatments vary from topical applications and oral medications to advanced therapies such as hair transplant surgeries and light therapy. The primary drivers include the rising prevalence of alopecia conditions due to factors such as stress, hormonal imbalances, and unhealthy lifestyles. Furthermore, technological advancements in hair transplant procedures and public awareness around hair loss treatments contribute to its use. Increased disposable income globally also allows more individuals access to these treatments. However, the high costs of surgical treatments and potential side effects associated with long-term pharmacological therapies act as significant restraining factors. The lack of reimbursement policies for hair loss procedures further hinders its use. The stringent regulatory approval process for new treatments can impede the launch of innovative solutions. Moreover, there is a substantial challenge in meeting diverse consumer expectations and maintaining ethical standards in marketing cosmetic treatments. Significant opportunities include the potential for new treatment formulations and less invasive surgical techniques, which may offer safer options with reduced recovery times.
Alopecia Treatment Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alopecia Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alopecia Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Treatment Market, highlighting leading vendors and their innovative profiles. These include Aclaris Therapeutics, Inc., AnaptysBio Inc., BiologicsMD, Inc., Cipla, Inc., Cirrus Hair Centers, Curallux, LLC, Daiichi Sankyo Inc., DR. KURT WOLFF GMBH & CO. KG, Dr. Reddy's Laboratories Ltd, Eli Lilly and Company, Fagron NV by Omega Pharma, Follica, Inc., HCell Inc., iGrow Laser, iRestore Hair Growth System, Johnson & Johnson Services, Inc, KNOW Bio LLC, Pfizer Inc., RepliCel Life Sciences Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Theradome GB, Transitions Hair Pty Ltd., Viviscal, and Zocdoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Alopecia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease Type
    • Alopecia Areata
    • Alopecia Totalis
    • Alopecia Universalis
    • Androgenetic Alopecia
    • Cicatricial Alopecia
    • Traction Alopecia
  • Route of Administration
    • Injectable
    • Oral
    • Topical
  • Gender
    • Female
    • Male
  • Treatment Option
    • Anthralin
    • Corticosteroid
    • JAK Inhibitors
    • Methotrexate
    • Topical Immunotherapy
  • End User
    • Dermatology Clinics
    • Homecare Setting

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Alopecia Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alopecia Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Alopecia Treatment Market?
  4. What is the market share of the leading vendors in the Alopecia Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Alopecia Treatment Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Alopecia Treatment Market, by Disease Type
  7. Alopecia Treatment Market, by Route of Administration
  8. Alopecia Treatment Market, by Gender
  9. Alopecia Treatment Market, by Treatment Option
  10. Alopecia Treatment Market, by End User
  11. Americas Alopecia Treatment Market
  12. Asia-Pacific Alopecia Treatment Market
  13. Europe, Middle East & Africa Alopecia Treatment Market
  14. Competitive Landscape
  15. Competitive Portfolio
Companies Mentioned
  • Aclaris Therapeutics, Inc.
  • AnaptysBio Inc.
  • BiologicsMD, Inc.
  • Cipla, Inc.
  • Cirrus Hair Centers
  • Curallux, LLC
  • Daiichi Sankyo Inc.
  • DR. KURT WOLFF GMBH & CO. KG
  • Dr. Reddy's Laboratories Ltd
  • Eli Lilly and Company
  • Fagron NV by Omega Pharma
  • Follica, Inc.
  • HCell Inc.
  • iGrow Laser
  • iRestore Hair Growth System
  • Johnson & Johnson Services, Inc
  • KNOW Bio LLC
  • Pfizer Inc.
  • RepliCel Life Sciences Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Theradome GB
  • Transitions Hair Pty Ltd.
  • Viviscal
  • Zocdoc, Inc.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Alopecia Treatment Market
The Global Alopecia Treatment Market size was estimated at USD 3.26 billion in 2023 and expected to reach USD 3.53 billion in 2024.
The Global Alopecia Treatment Market to grow USD 5.69 billion by 2030, at a CAGR of 8.27%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.